603168: reply to the inquiry letter from the controlling shareholder and the actual controller on the abnormal fluctuation of Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168) stock transaction: Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168) the inquiry letter on the abnormal fluctuation of Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168) stock transaction sent by your company has been received. As the controlling shareholder of your company, after careful self-examination, we hereby reply to the relevant matters as follows: 1. As of the date of this reply, The company has no material information that should be disclosed but not disclosed by your company. 2、 As of the date of this reply, the company has no major events involving your company in the planning stage, including but not limited to major asset restructuring, share issuance, acquisition, debt restructuring, business restructuring, asset divestiture, asset injection, share repurchase, equity incentive, bankruptcy reorganization, major business cooperation, introduction of strategic investors and other major events